June 10 (Reuters) - Neurotrope Inc NTRP.O :
* NEUROTROPE ANNOUNCES STRATEGIC PARTNERSHIP WITH BRYOLOGYX
FOR
SUPPLY OF SYNTHETIC BRYOSTATIN-1 AND CONTINUATION OF THE
NATIONAL CANCER INSTITUTE (NCI) TRIAL FOR CHILDHOOD LEUKEMIA
* NEUROTROPE - UNDER TERMS, BRYOLOGYX WILL SUPPLY CO WITH
SPECIFIED AMOUNTS OF SYNTHETIC, GMP-GRADE BRYOSTATIN-1.,
MANUFACTURED BY AMRI GROUP
* NEUROTROPE - BRYOLOGYX WILL PAY FEE ON GROSS REVENUES
GENERATED
BY COMMERCIAL SALE OF BRYOSTATIN-1 PRODUCT SOLD BY BRYOLOGYX
Source text for Eikon: ID:nPn1L1PM6a
Further company coverage: NTRP.O
((Reuters.Briefs@thomsonreuters.com;))